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TESTING A SUBTYPE-SPECIFIC GP41 AMPLIFICATION METHOD FOR GENOTYPING INDIVIDUALS 
INFECTED BY HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 IN THE BRAZILIAN POPULATION OF 
ITAJAÍ, SOUTH BRAZIL
Liã Bárbara ARRUDA(1,2), Laura I. WEBER(3), Marisa dos SANTOS(2), Edson M. KAWAKUBO(2) & Ana Maria B. MARTÍNEZ(4)
SUMMARY
The method used by YAGYU et al. for the subtype-specific polymerase chain reaction (PCR) amplification of the gp41 
transmembrane region of the human immunodeficiency virus type-1 (HIV-1) env gene, was tested. HIV-1 proviral DNA from 100 
infected individuals in Itajaí, South Brazil was used to analyze this method. Seventy individuals were determined according to this 
method as having PCR products at the expected size for subtypes B, C, D and F. Of these individuals, 26 (37.1%) were observed as 
having the expected amplification for subtype C, and 42 (60%) were observed as having the expected products for subtypes B and 
D. Of the subtype B and D amplicons, 16 (22.9%) were classified as subtype D, and 26 (37.1%) were classified as subtype B. Two 
individuals (2.9%) had amplicons that were observed after subtype F-specific amplification was performed. Sequencing and comparing 
the patient sequences to reference sequences confirmed the classification of sequences of subtypes C and B. However, sequences that 
were falsely determined as being D and F in the PCR assay were determined as being subtypes C and B, respectively, by sequence 
analysis. For those individuals from whom no amplified products were obtained, a low viral load that was indicated in their patient 
history may explain the difficulty in subtyping by PCR methods. This issue was demonstrated by the results of ANOVA when testing 
the effect of viral load on the success of PCR amplification. The alignment of the obtained sequences with HIV-1 reference sequences 
demonstrated that there is high intra-subtype diversity. This indicates that the subtype-specific primer binding sites were not conserved 
or representative of the subtypes that are observed in the Brazilian populations, and that they did not allow the correct classification of 
HIV-1 subtypes. Therefore, the proposed method by YAGYU et al. is not applicable for the classification of Brazilian HIV-1 subtypes.
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INTRODUCTION
Human immunodeficiency viruses types 1 and 2 (HIV-1 and HIV-2), 
which are responsible for the Acquired Immunodeficiency Syndrome 
(AIDS), were introduced into the human population during the 20th 
century. In the Americas, the first recognized case of HIV-1 subtype B 
was observed in 198110. From that first observed case until June 2011 
more than six hundred thousand cases of AIDS have been detected in 
Brazil. Approximately thirty thousand of these cases were observed in 
the Santa Catarina State of South Brazil15. A large number of reported 
cases are likely to be from the city of Itajaí in South Brazil. Port cities, 
such as Itajaí, are subject to a large influx of people from all around the 
world. Therefore, these cities are a main point of entry for new strains of 
HIV, resulting in the increased genetic diversity of HIV13,14.
HIV-1 strains are divided into different groups, subtypes, and sub-
subtypes according to their sequence. The main group (M) includes the 
majority of subtypes that are circulating in the human population (A, B, C, 
D, F, G, H, J and K), including approximately fifty circulating recombinant 
forms (CRFs) of HIV-1 that have been described worldwide11,18. The 
viral env gene encodes a precursor glycoprotein gp160 that is processed 
intracellularly to produce the native form of the envelope complex. The 
envelope complex comprises three gp120 surface subunits and three gp41 
transmembrane subunits that are associated with each other by noncovalent 
interactions. The composition of the gp120-gp41 complex is related to the 
ability of the virus to infect host cells5,21. The env gene is observed to have 
highly variable domains that are interspersed between conserved regions 
of gp120. These variable regions are distinctive of the HIV-1 subtypes4,17. 
The high level of heterogeneity observed in the gp120 coding region 
led to the analysis of the gp41 coding region as an alternative region for 
the identification of HIV-1 subtypes using short nucleotide sequences1. 
Phylogenetic studies demonstrated that the gp41 sequence and the C2-V3 
nucleotide sequence of gp120 showed concordance in the classification 
of HIV-1 subtypes1,17. Additionally, conserved regions in the gp41 coding 
region were identified, allowing the design of primers for subtype-specific 
amplification and identification of HIV-129.
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HIV diversity is an important issue for disease progression and 
transmission, the diagnosis and measurement of viral load, response to 
antiretroviral therapy and drug resistance, as well as immune response 
and vaccine development11,17,27. The diversity of HIV is also important for 
recognizing geographic boundaries of subtype distributions, identifying 
modes and routes of transmissions and identifying new recombinant 
forms of HIV13,14. 
YAGYU et al.28,29 described a rapid and simple method for the 
identification of HIV-1 subtypes by PCR amplification of a region of gp41 
using subtype-specific primers. Therefore, our aim was to test whether the 
method of YAGYU et al.29 could classify HIV-1 subtypes in seropositive 
individuals from the population of Itajaí (Santa Catarina, South Brazil).
MATERIAL AND METHODS
1. Population and sampling: The Laboratório Municipal de Itajaí 
(LMI) is a laboratory of the Brazilian Network for CD4+/CD8+ Cell 
Count and HIV Viral Load, located in the city of Itajaí, Santa Catarina 
in South Brazil. The LMI is a reference laboratory for highly complex 
and diagnostic exams that serves patients from Itajaí and neighboring 
towns. However, HIV subtyping is only possible when genotyping is 
performed in the Lacen laboratory of Florianópolis, which is the main 
city of the Santa Catarina State. Patients located in Itajaí who were 
observed in the clinic for the routine examination of CD4+/CD8+ T 
cell counting and plasma HIV viral load were invited to participate in 
this research. Individuals who volunteered (n = 100) were over 18 years 
of age, gave their approval for the use of their samples and signed an 
informed consent. This research was approved by the Ethical Committee 
of the Universidade do Vale do Itajaí (UNIVALI).
Viral load (highest recorded, last recorded and mean of the last 
six exams) for each patient (n = 98) was determined by the NASBA 
(Nuclisens, Bioméreux) method. The viral load for each patient was 
used for a comparison with the HIV-1 subtype that was detected by 
PCR amplification using the method of YAGYU et al.29. Patients also 
completed a form indicating their age and the mode by which they 
believed they were infected. Blood samples were collected at the LMI 
laboratory in tubes that contained EDTA between October and December 
of 2006.
2. DNA extraction: Blood samples were centrifuged at 2,500 x g for 
15 min at room temperature. The plasma was removed and the buffy coat 
was washed with 2:1 ACK solution (0.15 M NH4Cl; 0.01 M KHCO3; 0.1 
mM Na2EDTA) several times until all red blood cells were removed. After 
each wash, the cells were centrifuged at 500 x g for five min. The samples 
were then resuspended in PBS (8.09 mM Na2HPO4; 0.14 M NaCl; 1.47 
mM KH2PO4; 2.68 mM KCl) and centrifuged at 500 x g for five min. 
The supernatant was then removed. These samples were transported on 
ice to the Molecular Genetics Laboratory of the University (UNIVALI), 
where they were stored at -75 °C until genomic DNA extraction was 
performed. DNA extraction was performed by resuspending the pellet in 
700 µL of lysis buffer (10 mM Tris-HCl, pH 7.4; 5 mM EDTA, pH 8.0; 
20% SDS). Subsequently, 25 µL of Proteinase-K (20 mg/mL) was added, 
and the mixture was incubated at 57 °C for 2-3 h. After the incubation 
was complete, Phenol/Chloroform purification was performed. The 
DNA was precipitated using chilled, absolute ethanol and resuspended 
in 30 µL of TE buffer (10 mM Tris-HCl, pH 7.4; 1 mM EDTA, pH 8.0).
3. Amplification by HIV-1 subtype-specific primers and 
sequencing: The gp41 region from the proviral HIV-1 DNA was 
amplified by PCR using subtype-specific primers and methods as 
described by YAGYU et al.29 (Table 1). This method consists of 
sequential, nested PCR amplification steps that result in the amplification 
of different DNA fragments of specific sizes (Table 1) based on the 
HIV-1 subtype. For example, the BECO5 and BECO3 primers are the 
first round primers for all of the HIV-1 subtypes. For the nested PCR, 
the first PCR product is used as the template, the forward primer is the 
BE-ANCH primer, and the specificity of amplification is determined by 
the reverse primers B-SPEC, C-SPEC, E-SPEC or F-SPEC (Table 1). For 
the BE-ANCH:B-SPEC and BE-ANCH:E-SPEC primer pairs, a third 
amplification step must be performed to distinguish the B and D and the 
A, E and G subtypes, respectively (Table 1). The first PCR product is 
always used as the template after perceiving the expected fragment in 
the second-round PCR.
Each 25 µL PCR reaction contained 1 x PCR buffer, 1.5 mM MgCl2, 1 
µM of each primer, 0.2 mM of each dNTP and 1 U Taq DNA polymerase. 
The PCR template was composed of 1 µL of proviral DNA for the first PCR 
amplification, and 1 µL of the first-round PCR product was diluted 1:10 for 
all subsequent PCR amplification steps. The thermocycler was programmed 
as follows: 1 cycle of three min at 94 °C, followed by 35 cycles of one 
min at 94 °C, 1.5 min at 50 °C, and 1.5 min at 72 °C, and a final cycle 
of three min at 72 °C. The PCR products were perceived after horizontal 
electrophoresis using a 1.5% agarose gel and ethidium bromide staining. 
Molecular markers of 50 bp and 100 bp were used as reference markers.
DNA fragments obtained sizes that were close to the expected length 
after subtype-specific amplification from two individuals of each subtype 
and a representative for all of the subtype-specific fragments that were 
amplified were selected for sequencing. These fragments were isolated 
from the gel and purified using Ultrafree-DA (Millipore) filter units 
by centrifuging the column containing the DNA for 13 min at 5,000 x 
g. DNA was precipitated by ethanol precipitation and resuspension in 
water. The DNA was then sent to the sequencing laboratory of Macrogen, 
Inc. company, Korea (www.macrogen.com) for sequence analysis. 
Sequencing analysis was conducted under BigDye™ terminator cycling 
conditions. The reacted products were purified using ethanol precipitaion 
and were run using Automatic Sequencer 3730XL.
4. Data analysis: The sequences were edited using the CHROMAS 
v.2.31 (Technelysium Pty Ltd, 2005) software. The alignment of the 
sequences to the subtype reference sequences that were obtained from 
the online HIV database (http://hiv-web.lanl.gov) was performed using 
the ClustalW online tool (http://bioweb.pasteur.fr/seqanal/interfaces/
clustalw-simple.html). Similarities between the patient sequences that 
were obtained in this study to other sequences in the NCBI HIV database 
(National Center for Biotechnology Information) were determined using 
the BLAST online tool (http://ncbi.nlm.nih.gov//BLAST). To verify the 
subtypes that were classified, a maximum likelihood phylogenetic tree 
was constructed based on the Tamura-Nei model using env reference 
sequences from the HIV database to determine the phylogenetic 
locations of the sequences from the patients that were subtyped using 
the method of YAGYU et al.29. Confidence of the branches was evaluated 
by bootstrapping 500 replications. These analyses were conducted using 
Mega version 525. HIV-1 g41 proviral sequences were named according 
to HIV-1 nomenclature guidelines18 and submitted to GenBank.
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The effect of the viral load for each patient on the amplification of 
the gp41 region by the PCR method as described by YAGYU et al.29 was 
evaluated by an ANOVA test after normalizing the viral load data by a 
log transformation. The statistical package STATISTICA for Windows, 
version 5.1 (Statsoft, Inc.), was used to determine the mean viral load 
and standard error. This software was also used to log-transform these 
data and for the ANOVA test of significance (p < 0.05).
RESULTS
1. Population: The age and mode of HIV infection indicated by each 
patient are presented in Fig. 1. The average age of the participants was 40 
± 9.6 years; 53% of the patients were female and 47% were male (Fig. 
1A). The predominant mode of transmission indicated by the patients 
was sexual transmission. A large number of patients (33%) did not know 
the mode by which they were infected (Fig. 1 B).
2. Viral load of patients and detection of HIV subtypes by PCR: 
In general, higher viral loads were observed in male patients than in 
female patients (Table 2). However, the viral load of the males had a 
high level of variability, and the differences in viral load between males 
and females were not significant (Last viral load, p = 0.331; mean viral 
load, p = 0.136; highest viral load, p = 0.061). 
The successful amplification of subtype-specific products by PCR 
was reduced for patients with a lower viral load. This held true when the 
viral load was measured as the last recorded viral load of the patient, as 
the mean of the last six viral loads obtained, or as the highest viral load 
recorded for the history of the patient. Overall, the individuals whose 
proviral sequences could not be PCR-amplified were those patients 
who had lower viral loads (Fig. 2, Table 2). When comparing patients 
whose proviral sequences could be PCR-amplified with patients whose 
proviral sequences could not be amplified, an ANOVA significance test 
Table 1 
Primer sequences and amplification steps for HIV-1 subtype-specific amplification following the method of YAGYU et al.29
Primer
Primer sequence 5’-3’ Expected HIV-1 Subtype (Product size)1st step 2nd step 3rd step
F: BECO5 
R: BECO3
GGCATCAAACAGCTCCAGGCAAG
AGCAAAGCCCTTTCTAAGCCCTGTCT
A, B, C, D, E, F and G
F: BE-ANCH TCCTGGCTGTGGAAAGATACCTA
R: B-SPEC GTCCCCTCGGGGCTGGGAGG B and D (441 bp)
F: 5'D
R: 3'D
ACCACTAATGTGCCCTGGAACT
AGGAGGGTCTGAAATGACAGA
D (350 bp)
B (no product)
R: C-SPEC AGACCCCAATACTGCACAAGACTT C (697 bp)
R: E-SPEC GTCTCAGTCCCTTGAGACTGCTG A, E and G (645 bp)
F: 5'A
R: 3'A
GANAACATGACCTGGCTGC
TCTATAACCCTATCTGTCCAGCCA
A (644 bp)
F: 5'E
R: 3'E
CAGGAAAGGAATGAAAAGGATTTGTTA
ATAACCCTATCTGTCCACCCC
E (554 bp)
F: 5'G
R: 3'G
ACAATTACACATACCACATATACAGCC
TCTATAACCCTATCTGTCCAGTT
G (606 bp)
R: F-SPEC AACAGCTCTACCAGCTCTTTGCAAA F (778 bp)
F: forward primer; R: reverse primer.
Fig 1 - Age group and mode of transmission for HIV-1 infected patients included in this study.
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confirmed that there was a significant difference between the mean value 
of the viral load of the last six exams or for the highest value of the viral 
load recorded between these two patient populations (Table 2, Fig. 2). 
In accordance with these data, it was not possible to subtype individuals 
whose highest viral load was less than 60,000 copies/mL or who had a 
mean value that was less than 30,000 copies/mL.
3. Identification of subtype by the PCR testing method: The 
analysis of the PCR products that were obtained after the subtype-
specific amplification indicated the presence of numerous non-specific 
amplicons. Nonetheless, the annealing temperature was maintained at 
50 °C as described previously. PCR products at the expected size for the 
different HIV-1 subtypes were obtained for seventy individuals using 
the previously described method29. None of the amplified sequences 
corresponded to subtypes A, E or G (Table 3). For 26 (37.1%) patients, 
an amplified fragment of 676 bp or 698 bp was observed, which is close 
to the expected size (697 bp) for subtype C-specific amplification. For 
42 (60%) individuals, an amplified fragment of 442 bp was observed, 
which is close to the expected size for the subtype B/D strains. Among 
these 42 patients, the expected 350-bp fragment after D-subtype specific 
amplification was observed for 16 (22.9%) patients. Therefore, the 
remaining 26 individuals (37.1%) who were not observed to have specific 
amplification using subtype D-specific primers were classified as subtype 
B. An amplified fragment of 782 bp was observed for two individuals, 
which was close to the expected size (778 bp) after subtype F-specific 
amplification (Table 3). 
4. Comparing patient sequences to the HIV-1 subtype reference 
sequences: All of the sequences that were classified as subtypes B 
and C were correctly assigned to their respective HIV-1 subtypes after 
being aligned with the HIV-1 reference sequences and clustered in 
their respective subtype branches of the phylogenetic tree that was 
constructed (Fig. 3). Therefore, the method of YAGYU et al.29 was 
able to correctly identify sequences that were subtypes B and C (Table 
3, Fig. 3). However, the sequences that were classified as subtypes D 
and F according to the method by YAGYU et al.29 were incorrectly 
classified. The sequences that were classified as subtype D clustered 
phylogenetically with the subtype C reference sequences with 100% 
confidence (bootstrap value). Both of the subtype F sequences that 
were classified by the YAGYU et al.29 method were more similar to 
the subtype B reference sequences and clustered with the subtype B 
branch of the phylogenetic tree (Fig. 3).
Table 2
Mean viral loads that were obtained from all patients that were included in this study, their success in subtype-specific PCR amplification and the results of the 
ANOVA test of the significance of the effect of viral load on the success of the amplification
Sex of the 
Patients (N)
Means of HIV viral loads in the patients of Itajaí city (Number of copies/mL)
Highest value recorded/patient Mean of the last six exams/patient Value of the last exam/patient
Total
Amplified 
subtype by 
PCR
Non-amplified 
subtype by 
PCR
Total
Amplified 
subtype by 
PCR
Non-amplified 
subtype by 
PCR
Total
Amplified 
subtype by 
PCR
Non-amplified 
subtype by 
PCR
Male (45) 189,715 244,049 55,970 65,618 81,044 27,646 31,988 39,471 13,570
Female (53) 73,144 96,016 15,203 29,780 39,796 4,406 31,720 42,770 3,727
Total (98) 126,670 163,688* 34,130* 46,236 58,652** 15,196** 31,843 41,262NS 8,297NS
*F = 5.87, p = 0.017; **F = 7.24, p = 0.008; NS = Non-significant.
Fig. 2 - Detection of HIV-1 subtype by PCR amplification compared to viral load 
measurements for each patient. The viral load was calculated as the last recorded viral load 
obtained from the patient (lower panel), as the mean of the last six viral load measurements 
(middle panel) and as the highest value (upper panel) that was recorded in the patient history.
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The subtype C proviral amplicons that were correctly assigned by the 
method of YAGYU et al.29 were of two different sizes when amplified by 
the subtype-specific primers. One amplicon, identified as 06BR.IJ003, was 
of 698 bp, very close in size to the expected fragment. The second 676-bp 
fragment was 21 bp shorter and was identified as 06BR.IJ019 (Table 3). 
When looking for similarities in NCBI database, it was discovered that 
the 676-bp fragment (06BR.IJ019) shared a 93% sequence identity with 
a recombinant BC subtype (GenBank accession number EF091932) and 
a 92% sequence identity with two subtype C viruses (GenBank accession 
number AY563170 and AB254148). This fragment clustered with a 99% 
confidence interval within the subtype C and recombinant subtype BC 
branches of the phylogenetic tree of the HIV reference sequences (Fig. 
3). It also grouped with the subtype C sequence (82% confidence) that 
corresponded to a Brazilian male from the city of Porto Alegre in South 
Brazil that was recorded in 19927. The other subtype C sequence (06BR.
IJ003) had a 93% sequence identity with other subtype C viruses (GenBank 
accession numbers AY727526, U09126 and U15121) and also showed a 
93% identity to a subtype A virus (GenBank accession number AY751057). 
In the phylogenetic analysis (Fig. 3), the 06BR.IJ003 sequence was 
clustered within the subtype C branch with a 99% degree of confidence.
A total of 98-99% of the subtype D sequence (06BR.IJ039) showed 
a 92% sequence identity with subtype C viruses (GenBank accession 
number U39234 and AY727527) and with a virus that did not have a 
specified subtype (GenBank accession number U39238). By phylogenetic 
analysis, this sequence clustered together with a subtype C sequence 
(06BR.IJ003) with 99% confidence (Fig. 3). The second subtype D 
sequence (06BR.IJ093) also showed high sequence identity (92-93%) 
with subtype C viruses (GenBank accession numbers AY669740, 
AY727525 and U39234) and with a subtype BC recombinant virus 
(GenBank accession number EF091932). This sequence was clustered 
with 100% confidence with the branch in the phylogenetic tree that 
contained all of the subtype C reference sequences that were included 
in the analysis (Fig. 3).
Both of the subtype F sequences that were classified (06BR.
IJ026 and 06BR.IJ083) were 4 bp longer (782 pb) than the expected 
Table 3
Summary of the results of HIV-1 subtyping following subtype-specific PCR determination and analysis of DNA fragments that were close in size to the expected 
fragment for different subtypes as described by YAGYU et al.29. The viral sequences obtained in this study were compared to HIV-1 reference strains and entered into 
GenBank with the correct HIV-1 subtypes
Subtype-specific PCR determination Amplicons obtained from patients of Itajaí city 
Expected 
subtype
Expected size 
(bp)
Number of 
individuals (%)
Fragment size 
(bp) Codes of sequences deposited in GenBank* Correct subtype**
A/E/G 645 None None None None
B 441 26 (37.1%) 442 06BR.IJ007 (EU189139)06BR.IJ068 (EU189143)
B
B
C 697 26 (37.1%) 698676
06BR.IJ003 (EU189138) 
06BR.IJ019 (EU189140)
C
C
D 350 16 (22.9%) 350 06BR.IJ093 (EU189145)06BR.IJ039 (EU189142)
C
C
F 778 2 (2.9%) 782 06BR.IJ026 (EU189141)06BR.IJ083 (EU189144)
B
B
No subtype detected 30 (excluded)
*(Accession number); **Based on similarity with HIV-1 reference sequences.
Fig. 3 - Maximum likelihood phylogenetic analysis of env reference sequences with Itajaí 
city patient sequences (in bold, see Table 2) that were classified by the method of YAGYU et 
al.29. HIV-1 subtypes that were predicted by this method are indicated in brackets. Reference 
sequences of the env gene subtypes that were obtained from the HIV-1 database are represented 
by the corresponding subtype and the GenBank accession number. Numbers on the branches 
represent the confidence of the branches that were obtained by 500 bootstrap replications.
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fragment size and were more similar to subtype B and recombinant 
subtype BF reference sequences. A total of 97-100% of the fragment 
sequences showed a 91% sequence identity with subtype B (GenBank 
accession number AY247225) and recombinant subtype BF (GenBank 
accession number DQ358811) viruses. In the phylogenetic tree of HIV 
reference sequences, both sequences clustered with each other with 
100% confidence but clustered on the subtype B branch with only 36% 
confidence (Fig. 3).
5. Degree of specificity of the subtype-specific primers described 
by YAGYU et al.29: The analysis of the sequence alignments against 
subtype references from the HIV database (http://hiv-web.lanl.gov) 
showed that the subtype-specific primers that were described by YAGYU 
et al.29 were not 100% specific for all of the variants for the respective 
subtypes that were registered in the database (Fig. 4). For this figure, dots 
represent sites where there is an agreement between the primer sequences 
described by YAGYU et al.29 and sequences in the database, and the bases 
in black indicate sites where there were differences in the sequences. 
For example, under stringent amplification conditions, the forward BE-
ANCH primer would not have effectively recognized two of the subtype 
B, two of the subtype D, one subtype F1, and all four of the subtype C 
reference strains that were included in this analysis (Fig. 4). The same is 
true for the reverse primers indicated in Fig. 4, which also have divergent 
sequences in comparison with some of the subtype reference sequences. 
It was also observed that some of the subtype-specific primers amplified 
other HIV-1 subtypes using this method29. This was specifically observed 
Fig. 4 - Alignment of the primer binding sites for the primers described by YAGYU et al.29 which were used for HIV subtype-specific amplification of gp41 for this study. For the alignment, 
fragments that were obtained in this study are compared to reference sequences for subtypes B, C, D and F1 that were obtained from the HIV-1 database. Dots represent sequence homology 
with the original primer sequence described by YAGYU et al. The bases in black within the primer region represent divergent sequences from the respective primer sequence region. Underlined 
sequences represent the superpositions of primers. 
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in the amplification of variants of subtypes C and B using the subtype 
D- and F-specific primers, respectively.
DISCUSSION
As a consequence of their rapid in vivo turnover rate and frequent 
recombination events, the high mutation rates that are observed for HIV 
have resulted in high levels of genetic variability16,22 and an increasing 
variety of HIV-1 subtypes. The identification of predominant subtypes, 
the distribution of subtypes in the country, and the identification of 
new HIV-1 variants in the Brazilian population have been intensified to 
study the use of more efficient therapeutic drug treatments and for the 
development of HIV-1 vaccines. Therefore, researchers from developing 
countries are persistently looking for new, low-cost and efficient methods 
for subtype HIV-1. A promising method was described by YAGYU et 
al.29 that is predicated on the PCR amplification of the gp41 subunit of 
the env gene using subtype-specific primers. While this method showed 
satisfactory results in samples from HIV-1-infected individuals in the 
populations of Japan and Thailand, it did not show the same success 
using samples from the population of South Brazil.
This method failed to correctly assign certain variants of C and 
B subtypes that were identified in the Brazilian populations. The 
primers that were described by YAGYU et al.29 were not specific for 
some subtype variants of HIV-1 that were observed in the Brazilian 
populations because the primer binding regions were not adequately 
conserved to facilitate the subtype-specific amplification. The lack 
of subtype-specific primer binding explains the need to maintain less 
stringent amplification conditions (annealing temperature of 50 °C) 
using this method. However, the use of non-stringent amplification 
conditions led to the amplification of non-specific subtypes. Conversely, 
increasing the annealing temperature will result in a failure to amplify 
many of the subtype variants. As shown in Fig. 4, the primer binding 
regions are neither conserved nor representative enough to be used for 
the identification of Brazilian HIV-1 subtypes. This is a major detriment 
for using this method for subtype HIV-1 infected individuals from regions 
that maintain high levels of HIV-1 genetic diversity. High intra-subtype 
variation in the gp41 subunit was also observed. This raises the question 
of whether gp41 contains conserved regions that could allow different 
subtypes to be recognized.
Thirty percent of individuals could not be subtyped by the PCR 
method that was used in this study because of a failure to amplify 
subtype-specific PCR products. While a detriment to the specificity of 
the PCR amplification, the less stringent conditions used in this method 
should facilitate the amplification of all patient samples. Another subtype-
specific PCR method has also failed to amplify patient viral sequences 
(20%)12; therefore, this issue may be related to a history of low viral 
load for the patient (determined by plasma RNA levels) rather than to 
the PCR amplification method. This argument is supported by data that 
showed a significant effect of the viral load of the patient on the success 
of the subtype-specific amplification in this study (Fig. 2, Table 2). The 
highest viral load recorded for the patient and the mean viral load of the 
patient’s last six exams were evaluated in this study. Therefore, mean 
lifetime viral loads that are less than 30,000 copies/mL for a patient will 
significantly reduce the possibility of identifying the HIV-1 subtype that 
has infected an individual.
Studies have demonstrated that the frequency of various subtypes 
is dependent on geographical location. HIV-1 molecular epidemiology 
studies have already detected four subtypes in the Brazilian population: 
B, C, D, and F9,13,23. The HIV-1 B subtype is the most prevalent and 
has shown a decreasing frequency since 1993 (94% in São Paulo) to 
the period 1999-2001 (64% in Rio de Janeiro)20,26 to 2004 (23% in 
Santa Catarina)12. The frequency of subtype F viruses in the Brazilian 
population is highly dependent on the geographical location. Subtype F 
has been observed at a very low frequency in Northeast Brazil (2.7%)6, 
in the extreme of South Brazil (3%)13 and in São Paulo (6%)20. However, 
subtype F has been observed at moderate frequencies in Rio de Janeiro 
both in the period 1994-1997 (24.4%)8 and in the period 1999-2001 
(16.7%)26. Individuals that were infected with subtype C virus were 
identified at a frequency of 22% in 1997 in South Brazil13. In 2004 in 
the Santa Catarina State, subtype C virus was identified at a frequency 
of 48%12. In South Brazil, it was discovered in 2006 that 70% of HIV 
positive pregnant women were infected with C virus14 and that subtype 
C was at a frequency of 50% of the HIV-1-infected subjects in South 
Brazil14,23. Further studies showed that some HIV-positive individuals 
who were previously reported to be infected with subtype C virus 
were actually infected with the recombinant CRF31_BC variant22,24, 
representing 21.2% of the previously detected subtype C infection22. 
Both subtypes A and D are extremely rare, and they are detected only 
after several years of analysis3.
Therefore, the 40% frequency of the subtype B virus (37.1% 
recognized correctly by the method by YAGYU et al. in addition to the 
2.9% that was correctly identified as subtype B by sequencing) is higher 
than the frequencies that were identified for the city of Florianopolis in 
Santa Catarina State (23%) in 200412. Considering that the sequences 
that were classified by the method by YAGYU et al. as subtype D were 
later confirmed as subtype C by sequencing analysis and knowing that 
subtype D is extremely rare in the Brazilian population, we expect that 
the 16 individuals who were classified as having HIV-1 subtype D are 
actually infected with subtype C virus. If this is true, these data indicate 
that the subtype C frequency for Itajaí city in the Santa Catarina State 
for 2006 is 60%. However, the frequencies of subtypes B and C likely 
include recombinant forms of HIV-1 that cannot be distinguished by the 
gp41 region that was used in the YAGYU et al.29 method. The similarity 
of the incorrectly classified subtype D and F viruses to the recombinant 
forms of HIV-1 suggests that the gp41 region that is amplified is too short 
to clearly distinguish the recombinant forms that are frequently found 
in the Brazilian population2,3,9,19,22,24. Analyses of the sequences from 
the Brazilian recombinants CRF28_BF, CRF29_BF, and CRF31_BC 
have demonstrated that the gp41 region in the BF recombinant forms 
will produce a subtype B amplification fragment. The BC recombinant 
form will produce a subtype C amplification fragment. This clearly 
demonstrates a limitation of the YAGYU et al.29 method for subtype 
analysis in the Brazilian population. 
Finally, it can be concluded that the method described by YAGYU 
et al.29 is not effective for classifying HIV-1 subtypes in the Brazilian 
population because of the failure of the method in detecting some 
HIV-1 subtype variants and recombinant forms of HIV-1. Furthermore, 
because the primer binding sites were not conserved, the method is 
not representative enough to allow subtype-specific amplification 
of gp41.
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RESUMO
Teste da metodologia de amplificação subtipo-específica da 
gp41 para genotipagem de indivíduos infectados pelo Vírus da 
Imunodeficiência Humana tipo 1 na população de Itajaí, Sul do 
Brasil
A metodologia para amplificação subtipo-específica por PCR da 
região transmembrana do gene env (gp41) do HIV-1, descrita por Yagyu 
e colaboradores, foi testada a partir de DNA proviral de 100 pacientes 
infectados pelo HIV-1 de Itajaí, Sul do Brasil. Setenta indivíduos 
apresentaram produtos amplificados e correspondentes aos subtipos B, 
C, D e F de acordo com a metodologia escolhida. Destes indivíduos, 26 
(37,1%) apresentaram a amplificação esperada para o subtipo C de acordo 
com a metodologia; 42 (60%) apresentaram os produtos esperados para 
os subtipos B e D, sendo que na etapa seguinte de diferenciação destes 
subtipos, 16 (22,9%) corresponderam ao subtipo D e 26 (37,1%) ao 
subtipo B. Dois indivíduos (2,9%) mostraram produtos amplificados após a 
amplificação específica para o subtipo F. O sequenciamento e a comparação 
com sequências referências confirmou a subtipagem de HIV-1 C e B obtida 
pela metodologia. No entanto, indivíduos subtipados erroneamente como 
HIV-1 D e F pela metodologia, foram classificados pela comparação com 
sequências referências como subtipos C e B, respectivamente. Em relação 
aos indivíduos que não mostraram produtos amplificados, a baixa carga 
viral observada no histórico destes pacientes seria em parte responsável pela 
dificuldade na subtipagem pela metodologia de PCR, como demonstrado 
pelo resultado significativo no ANOVA ao testar o efeito da carga viral 
no sucesso da amplificação. O alinhamento das sequências obtidas com 
sequências referências de HIV-1 correspondentes à região da gp41 
demonstrou que há uma alta diversidade intra-subtipo e que as regiões 
a partir das quais foram desenhados os oligonucleotídeos iniciadores 
HIV-1 subtipo-específicos não são conservadas nem suficientemente 
representativas dos subtipos observados nas populações brasileiras para 
permitir sua correta identificação. Portanto, esta metodologia não é 
aplicável para populações virais brasileiras. 
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